Submitted by Riki Merrick on
SHIELD USCDI V7 Draft Adverse Events class comment
SHIELD requests ASTP/ONC to clarify what kind of Adverse Events are covered with this class. Does it cover all of these: CLIA-certified laboratories reporting on laboratory-developed tests (LDTs)), Adverse event reporting as part of FDA post-market surveillance and NIH Clinical Trials?







Submitted by mturchioe on
ANI's comment on USCDI draft v7: Adverse Events
The Alliance for Nursing Informatics (ANI) strongly supports the introduction of Adverse Events as a new USCDI data class. This addition represents a long-overdue formal acknowledgment of nursing's central role in patient safety surveillance. Registered nurses are the primary detectors, reporters, and documenters of adverse events across virtually all care settings, and the absence of a standardized, interoperable adverse event data class has long undermined cross-organizational patient safety data exchange. Standardizing both Adverse Event and Adverse Event Outcome will enable structured documentation to follow patients across care transitions, which is a critical gap in post-acute and transitional care settings where nursing leads handoff workflows. We advocate for vocabulary guidance that extends beyond the currently specified SNOMED CT to encompass nursing-sensitive adverse event categories, including patient falls, pressure injury staging events, and medication errors, and we encourage ONC to provide implementation guidance that supports embedded, point-of-care adverse event capture rather than reliance on siloed safety reporting systems.